Financials data is unavailable for this security.
View more
Year on year Joinn Laboratories China Co Ltd had net income fall -63.04% from 1.07bn to 396.99m despite a 4.78% increase in revenues from 2.27bn to 2.38bn. An increase in the cost of goods sold as a percentage of sales from 52.23% to 58.70% was a component in the falling net income despite rising revenues.
| Gross margin | 36.70% |
|---|---|
| Net profit margin | 5.86% |
| Operating margin | 9.63% |
| Return on assets | 1.31% |
|---|---|
| Return on equity | 1.71% |
| Return on investment | 1.58% |
More ▼
Cash flow in CNYView more
In 2023, Joinn Laboratories China Co Ltd did not generate a significant amount of cash. However, the company earned 622.88m from its operations for a Cash Flow Margin of 26.21%. In addition the company used 315.43m on investing activities and also paid 361.68m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 10.56 |
|---|---|
| Tangible book value per share | 9.98 |
More ▼
Balance sheet in CNYView more
| Current ratio | 3.62 |
|---|---|
| Quick ratio | 2.54 |
| Total debt/total equity | 0.0072 |
|---|---|
| Total debt/total capital | 0.0071 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -44.00% and -62.90%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.52% |
|---|---|
| Div growth rate (5 year) | 23.46% |
| Payout ratio (TTM) | 87.40% |
| EPS growth(5 years) | 24.71 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -82.51 |
More ▼
